美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
27241-228-01	27241-228	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311	N/A	ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	50 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-228-01)
27241-228-30	27241-228	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311	N/A	ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	50 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-228-30)
27241-229-01	27241-229	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311	N/A	ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	100 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-229-01)
27241-230-01	27241-230	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311	N/A	ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	200 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-230-01)
27241-230-30	27241-230	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311	N/A	ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	200 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-230-30)
27241-229-30	27241-229	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311	N/A	ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	100 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-229-30)
27241-227-30	27241-227	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311	N/A	ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	25 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-227-30)
27241-227-01	27241-227	HUMAN PRESCRIPTION DRUG	Topiramate	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311	N/A	ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	25 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-227-01)